Hamilton Wealth LLC Acquires New Stake in Regeneron Pharmaceuticals, Inc. $REGN

robot
Abstract generation in progress

Hamilton Wealth LLC has acquired a new stake of 12,581 shares, valued at approximately $7.07 million, in Regeneron Pharmaceuticals (NASDAQ:REGN) during Q3, making it their 21st largest position. Several other institutional investors also adjusted their holdings. Regeneron recently beat earnings estimates, declared an increased quarterly dividend, and holds a consensus “Moderate Buy” rating with an average price target of $802.27.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments